Arcellx (ACLX) Non Operating Income (2021 - 2025)
Arcellx (ACLX) recorded quarterly Non Operating Income of $5.6 million in Q4 2025, down 6.41% quarter-over-quarter from $6.0 million in Q3 2025, and down 25.94% on a YoY basis from $7.6 million in Q4 2024.
Arcellx (ACLX) Non Operating Income (2021 - 2025) Analysis & Trends
Arcellx's Non Operating Income history runs 5 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- In Q4 2025, Non Operating Income fell 25.94% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at $24.2 million (down 25.0% YoY), while the FY2025 annual figure was $24.2 million, down 25.0% from the prior year.
- Non Operating Income was $5.6 million for Q4 2025 at Arcellx, down from $6.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $8.6 million in Q1 2024 to a low of $1000.0 in Q1 2021.
- Historically, Non Operating Income has averaged $3.9 million across 5 years, with a median of $5.4 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income surged 51700.0% in 2022, then slipped 26.41% in 2025.
- A 5-year view of Non Operating Income shows it stood at $28000.0 in 2021, then soared by 3514.29% to $1.0 million in 2022, then surged by 440.22% to $5.5 million in 2023, then surged by 38.58% to $7.6 million in 2024, then slipped by 25.94% to $5.6 million in 2025.
- The last three Non Operating Income figures came in at $5.6 million (Q4 2025), $6.0 million (Q3 2025), and $6.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 7.97 Mn |
| Jun 30, 2024 | 8.13 Mn |
| Mar 31, 2024 | 8.61 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Sep 30, 2023 | 5.52 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 518,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |